Transcription of Genetic Testing – Medicare Advantage Coverage Summary
{{id}} {{{paragraph}}}
Page 1 of 23 UHC MA Coverage Summary : Genetic Testing Proprietary Information of UnitedHealthcare. Copyright 2020 United HealthCare Services, Inc. Coverage Summary Genetic Testing Policy Number: G-003 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 02/14/2008 Approved by: UnitedHealthcare Medicare Benefit Interpretation Committee Last Review Date: 08/18/2020 Related Medicare Advantage Policy Guidelines: BRCA1 and BRCA2 Genetic Testing Cytogenic Studies ( ) Genetic Testing for Lynch Syndrome Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing Molecular Pathology/ Genetic Testing Reported with Unlisted Codes Molecular Pathology/Molecular Diagnostics/ Genetic Testing Tier 2 Molecular Pathology Procedures This information is being distributed to you for personal reference. The information belongs to UnitedHealthcare and unauthorized copying, use, and distribution are prohibited.
Genetic Testing Page 1 of 19 UnitedHealthcare Medicare Advantage Coverage Summary Approved 11/16/2021 Proprietary Information of UnitedHealthcare.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}